Direct-to-consumer Disease Risk and Health Test Market, Global Outlook and Forecast 2022-2028
The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
This report contains market size and forecasts of Direct-to-consumer Disease Risk and Health Test in Global, including the following market information:
Global Direct-to-consumer Disease Risk and Health Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Direct-to-consumer Disease Risk and Health Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Celiac Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Direct-to-consumer Disease Risk and Health Test include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center and Invitae, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Direct-to-consumer Disease Risk and Health Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Direct-to-consumer Disease Risk and Health Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Type, 2021 (%)
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Application, 2021 (%)
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Direct-to-consumer Disease Risk and Health Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Direct-to-consumer Disease Risk and Health Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Direct-to-consumer Disease Risk and Health Test in Global, including the following market information:
Global Direct-to-consumer Disease Risk and Health Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Direct-to-consumer Disease Risk and Health Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Celiac Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Direct-to-consumer Disease Risk and Health Test include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center and Invitae, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Direct-to-consumer Disease Risk and Health Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Direct-to-consumer Disease Risk and Health Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Type, 2021 (%)
- Celiac Disease
- Parkinson Disease
- Alzheimer Disease
- Other
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Application, 2021 (%)
- Online
- Offline
Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Direct-to-consumer Disease Risk and Health Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Direct-to-consumer Disease Risk and Health Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Direct-to-consumer Disease Risk and Health Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Direct-to-consumer Disease Risk and Health Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIRECT-TO-CONSUMER DISEASE RISK AND HEALTH TEST OVERALL MARKET SIZE
2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028
2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.2 Top Global Direct-to-consumer Disease Risk and Health Test Companies Ranked by Revenue
3.3 Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies
3.4 Top 3 and Top 5 Direct-to-consumer Disease Risk and Health Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.6.1 List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Direct-to-consumer Disease Risk and Health Test Market Size Markets, 2021 & 2028
4.1.2 Celiac Disease
4.1.3 Parkinson Disease
4.1.4 Alzheimer Disease
4.1.5 Other
4.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
4.2.1 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
4.2.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
4.2.3 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
5.1.2 Online
5.1.3 Offline
5.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
5.2.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
5.2.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
5.2.3 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
6.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
6.2.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
6.2.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
6.2.3 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.3.2 US Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.3 Canada Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.4 Mexico Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.4.2 Germany Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.3 France Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.4 U.K. Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.5 Italy Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.6 Russia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.7 Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.8 Benelux Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.5.2 China Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.4 South Korea Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.5 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.6 India Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.6.2 Brazil Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6.3 Argentina Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.7.2 Turkey Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.3 Israel Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.4 Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.5 UAE Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 23andMe
7.1.1 23andMe Corporate Summary
7.1.2 23andMe Business Overview
7.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.1.4 23andMe Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.1.5 23andMe Key News
7.2 MyHeritage
7.2.1 MyHeritage Corporate Summary
7.2.2 MyHeritage Business Overview
7.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.2.5 MyHeritage Key News
7.3 LabCorp
7.3.1 LabCorp Corporate Summary
7.3.2 LabCorp Business Overview
7.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.3.4 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.3.5 LabCorp Key News
7.4 Myriad Genetics
7.4.1 Myriad Genetics Corporate Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.4.5 Myriad Genetics Key News
7.5 Ancestry.com
7.5.1 Ancestry.com Corporate Summary
7.5.2 Ancestry.com Business Overview
7.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.5.5 Ancestry.com Key News
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Corporate Summary
7.6.2 Quest Diagnostics Business Overview
7.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.6.5 Quest Diagnostics Key News
7.7 Gene By Gene
7.7.1 Gene By Gene Corporate Summary
7.7.2 Gene By Gene Business Overview
7.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.7.5 Gene By Gene Key News
7.8 DNA Diagnostics Center
7.8.1 DNA Diagnostics Center Corporate Summary
7.8.2 DNA Diagnostics Center Business Overview
7.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.8.5 DNA Diagnostics Center Key News
7.9 Invitae
7.9.1 Invitae Corporate Summary
7.9.2 Invitae Business Overview
7.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.9.4 Invitae Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.9.5 Invitae Key News
7.10 IntelliGenetics
7.10.1 IntelliGenetics Corporate Summary
7.10.2 IntelliGenetics Business Overview
7.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.10.5 IntelliGenetics Key News
7.11 Ambry Genetics
7.11.1 Ambry Genetics Corporate Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.11.5 Ambry Genetics Key News
7.12 Living DNA
7.12.1 Living DNA Corporate Summary
7.12.2 Living DNA Business Overview
7.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.12.4 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.12.5 Living DNA Key News
7.13 EasyDNA
7.13.1 EasyDNA Corporate Summary
7.13.2 EasyDNA Business Overview
7.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.13.5 EasyDNA Key News
7.14 Pathway Genomics
7.14.1 Pathway Genomics Corporate Summary
7.14.2 Pathway Genomics Business Overview
7.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.14.5 Pathway Genomics Key News
7.15 Centrillion Technology
7.15.1 Centrillion Technology Corporate Summary
7.15.2 Centrillion Technology Business Overview
7.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.15.5 Centrillion Technology Key News
7.16 Xcode
7.16.1 Xcode Corporate Summary
7.16.2 Xcode Business Overview
7.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.16.4 Xcode Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.16.5 Xcode Key News
7.17 Color Genomics
7.17.1 Color Genomics Corporate Summary
7.17.2 Color Genomics Business Overview
7.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.17.5 Color Genomics Key News
7.18 Anglia DNA Services
7.18.1 Anglia DNA Services Corporate Summary
7.18.2 Anglia DNA Services Business Overview
7.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.18.5 Anglia DNA Services Key News
7.19 African Ancestry
7.19.1 African Ancestry Corporate Summary
7.19.2 African Ancestry Business Overview
7.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.19.5 African Ancestry Key News
7.20 Canadian DNA Services
7.20.1 Canadian DNA Services Corporate Summary
7.20.2 Canadian DNA Services Business Overview
7.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.20.5 Canadian DNA Services Key News
7.21 DNA Family Check
7.21.1 DNA Family Check Corporate Summary
7.21.2 DNA Family Check Business Overview
7.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.21.5 DNA Family Check Key News
7.22 Alpha Biolaboratories
7.22.1 Alpha Biolaboratories Corporate Summary
7.22.2 Alpha Biolaboratories Business Overview
7.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.22.5 Alpha Biolaboratories Key News
7.23 Test Me DNA
7.23.1 Test Me DNA Corporate Summary
7.23.2 Test Me DNA Business Overview
7.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.23.5 Test Me DNA Key News
7.24 23 Mofang
7.24.1 23 Mofang Corporate Summary
7.24.2 23 Mofang Business Overview
7.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.24.5 23 Mofang Key News
7.25 Genetic Health
7.25.1 Genetic Health Corporate Summary
7.25.2 Genetic Health Business Overview
7.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.25.5 Genetic Health Key News
7.26 DNA Services of America
7.26.1 DNA Services of America Corporate Summary
7.26.2 DNA Services of America Business Overview
7.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.26.5 DNA Services of America Key News
7.27 Shuwen Health Sciences
7.27.1 Shuwen Health Sciences Corporate Summary
7.27.2 Shuwen Health Sciences Business Overview
7.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.27.5 Shuwen Health Sciences Key News
7.28 Mapmygenome
7.28.1 Mapmygenome Corporate Summary
7.28.2 Mapmygenome Business Overview
7.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.28.5 Mapmygenome Key News
7.29 Full Genomes
7.29.1 Full Genomes Corporate Summary
7.29.2 Full Genomes Business Overview
7.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.29.5 Full Genomes Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Direct-to-consumer Disease Risk and Health Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Direct-to-consumer Disease Risk and Health Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIRECT-TO-CONSUMER DISEASE RISK AND HEALTH TEST OVERALL MARKET SIZE
2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028
2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.2 Top Global Direct-to-consumer Disease Risk and Health Test Companies Ranked by Revenue
3.3 Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies
3.4 Top 3 and Top 5 Direct-to-consumer Disease Risk and Health Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.6.1 List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Direct-to-consumer Disease Risk and Health Test Market Size Markets, 2021 & 2028
4.1.2 Celiac Disease
4.1.3 Parkinson Disease
4.1.4 Alzheimer Disease
4.1.5 Other
4.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
4.2.1 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
4.2.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
4.2.3 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
5.1.2 Online
5.1.3 Offline
5.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
5.2.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
5.2.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
5.2.3 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
6.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
6.2.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
6.2.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
6.2.3 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.3.2 US Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.3 Canada Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.4 Mexico Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.4.2 Germany Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.3 France Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.4 U.K. Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.5 Italy Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.6 Russia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.7 Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.8 Benelux Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.5.2 China Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.4 South Korea Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.5 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.6 India Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.6.2 Brazil Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6.3 Argentina Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.7.2 Turkey Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.3 Israel Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.4 Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.5 UAE Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 23andMe
7.1.1 23andMe Corporate Summary
7.1.2 23andMe Business Overview
7.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.1.4 23andMe Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.1.5 23andMe Key News
7.2 MyHeritage
7.2.1 MyHeritage Corporate Summary
7.2.2 MyHeritage Business Overview
7.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.2.5 MyHeritage Key News
7.3 LabCorp
7.3.1 LabCorp Corporate Summary
7.3.2 LabCorp Business Overview
7.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.3.4 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.3.5 LabCorp Key News
7.4 Myriad Genetics
7.4.1 Myriad Genetics Corporate Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.4.5 Myriad Genetics Key News
7.5 Ancestry.com
7.5.1 Ancestry.com Corporate Summary
7.5.2 Ancestry.com Business Overview
7.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.5.5 Ancestry.com Key News
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Corporate Summary
7.6.2 Quest Diagnostics Business Overview
7.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.6.5 Quest Diagnostics Key News
7.7 Gene By Gene
7.7.1 Gene By Gene Corporate Summary
7.7.2 Gene By Gene Business Overview
7.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.7.5 Gene By Gene Key News
7.8 DNA Diagnostics Center
7.8.1 DNA Diagnostics Center Corporate Summary
7.8.2 DNA Diagnostics Center Business Overview
7.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.8.5 DNA Diagnostics Center Key News
7.9 Invitae
7.9.1 Invitae Corporate Summary
7.9.2 Invitae Business Overview
7.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.9.4 Invitae Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.9.5 Invitae Key News
7.10 IntelliGenetics
7.10.1 IntelliGenetics Corporate Summary
7.10.2 IntelliGenetics Business Overview
7.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.10.5 IntelliGenetics Key News
7.11 Ambry Genetics
7.11.1 Ambry Genetics Corporate Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.11.5 Ambry Genetics Key News
7.12 Living DNA
7.12.1 Living DNA Corporate Summary
7.12.2 Living DNA Business Overview
7.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.12.4 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.12.5 Living DNA Key News
7.13 EasyDNA
7.13.1 EasyDNA Corporate Summary
7.13.2 EasyDNA Business Overview
7.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.13.5 EasyDNA Key News
7.14 Pathway Genomics
7.14.1 Pathway Genomics Corporate Summary
7.14.2 Pathway Genomics Business Overview
7.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.14.5 Pathway Genomics Key News
7.15 Centrillion Technology
7.15.1 Centrillion Technology Corporate Summary
7.15.2 Centrillion Technology Business Overview
7.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.15.5 Centrillion Technology Key News
7.16 Xcode
7.16.1 Xcode Corporate Summary
7.16.2 Xcode Business Overview
7.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.16.4 Xcode Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.16.5 Xcode Key News
7.17 Color Genomics
7.17.1 Color Genomics Corporate Summary
7.17.2 Color Genomics Business Overview
7.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.17.5 Color Genomics Key News
7.18 Anglia DNA Services
7.18.1 Anglia DNA Services Corporate Summary
7.18.2 Anglia DNA Services Business Overview
7.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.18.5 Anglia DNA Services Key News
7.19 African Ancestry
7.19.1 African Ancestry Corporate Summary
7.19.2 African Ancestry Business Overview
7.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.19.5 African Ancestry Key News
7.20 Canadian DNA Services
7.20.1 Canadian DNA Services Corporate Summary
7.20.2 Canadian DNA Services Business Overview
7.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.20.5 Canadian DNA Services Key News
7.21 DNA Family Check
7.21.1 DNA Family Check Corporate Summary
7.21.2 DNA Family Check Business Overview
7.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.21.5 DNA Family Check Key News
7.22 Alpha Biolaboratories
7.22.1 Alpha Biolaboratories Corporate Summary
7.22.2 Alpha Biolaboratories Business Overview
7.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.22.5 Alpha Biolaboratories Key News
7.23 Test Me DNA
7.23.1 Test Me DNA Corporate Summary
7.23.2 Test Me DNA Business Overview
7.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.23.5 Test Me DNA Key News
7.24 23 Mofang
7.24.1 23 Mofang Corporate Summary
7.24.2 23 Mofang Business Overview
7.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.24.5 23 Mofang Key News
7.25 Genetic Health
7.25.1 Genetic Health Corporate Summary
7.25.2 Genetic Health Business Overview
7.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.25.5 Genetic Health Key News
7.26 DNA Services of America
7.26.1 DNA Services of America Corporate Summary
7.26.2 DNA Services of America Business Overview
7.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.26.5 DNA Services of America Key News
7.27 Shuwen Health Sciences
7.27.1 Shuwen Health Sciences Corporate Summary
7.27.2 Shuwen Health Sciences Business Overview
7.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.27.5 Shuwen Health Sciences Key News
7.28 Mapmygenome
7.28.1 Mapmygenome Corporate Summary
7.28.2 Mapmygenome Business Overview
7.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.28.5 Mapmygenome Key News
7.29 Full Genomes
7.29.1 Full Genomes Corporate Summary
7.29.2 Full Genomes Business Overview
7.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.29.5 Full Genomes Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Direct-to-consumer Disease Risk and Health Test Market Opportunities & Trends in Global Market
Table 2. Direct-to-consumer Disease Risk and Health Test Market Drivers in Global Market
Table 3. Direct-to-consumer Disease Risk and Health Test Market Restraints in Global Market
Table 4. Key Players of Direct-to-consumer Disease Risk and Health Test in Global Market
Table 5. Top Direct-to-consumer Disease Risk and Health Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
Table 9. List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 30. 23andMe Corporate Summary
Table 31. 23andMe Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 32. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 33. MyHeritage Corporate Summary
Table 34. MyHeritage Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 35. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 36. LabCorp Corporate Summary
Table 37. LabCorp Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 38. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 39. Myriad Genetics Corporate Summary
Table 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 41. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 42. Ancestry.com Corporate Summary
Table 43. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 44. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 45. Quest Diagnostics Corporate Summary
Table 46. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 47. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 48. Gene By Gene Corporate Summary
Table 49. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 50. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 51. DNA Diagnostics Center Corporate Summary
Table 52. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 53. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 54. Invitae Corporate Summary
Table 55. Invitae Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 56. Invitae Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 57. IntelliGenetics Corporate Summary
Table 58. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 59. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 60. Ambry Genetics Corporate Summary
Table 61. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 62. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 63. Living DNA Corporate Summary
Table 64. Living DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 65. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 66. EasyDNA Corporate Summary
Table 67. EasyDNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 68. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 69. Pathway Genomics Corporate Summary
Table 70. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 71. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 72. Centrillion Technology Corporate Summary
Table 73. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 74. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 75. Xcode Corporate Summary
Table 76. Xcode Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 77. Xcode Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 78. Color Genomics Corporate Summary
Table 79. Color Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 80. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 81. Anglia DNA Services Corporate Summary
Table 82. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 83. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 84. African Ancestry Corporate Summary
Table 85. African Ancestry Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 86. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 87. Canadian DNA Services Corporate Summary
Table 88. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 89. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 90. DNA Family Check Corporate Summary
Table 91. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 92. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 93. Alpha Biolaboratories Corporate Summary
Table 94. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 95. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 96. Test Me DNA Corporate Summary
Table 97. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 98. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 99. 23 Mofang Corporate Summary
Table 100. 23 Mofang Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 101. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 102. Genetic Health Corporate Summary
Table 103. Genetic Health Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 104. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 105. DNA Services of America Corporate Summary
Table 106. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 107. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 108. Shuwen Health Sciences Corporate Summary
Table 109. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 110. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 111. Mapmygenome Corporate Summary
Table 112. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 113. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 114. Full Genomes Corporate Summary
Table 115. Full Genomes Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 116. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 1. Direct-to-consumer Disease Risk and Health Test Market Opportunities & Trends in Global Market
Table 2. Direct-to-consumer Disease Risk and Health Test Market Drivers in Global Market
Table 3. Direct-to-consumer Disease Risk and Health Test Market Restraints in Global Market
Table 4. Key Players of Direct-to-consumer Disease Risk and Health Test in Global Market
Table 5. Top Direct-to-consumer Disease Risk and Health Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
Table 9. List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 30. 23andMe Corporate Summary
Table 31. 23andMe Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 32. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 33. MyHeritage Corporate Summary
Table 34. MyHeritage Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 35. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 36. LabCorp Corporate Summary
Table 37. LabCorp Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 38. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 39. Myriad Genetics Corporate Summary
Table 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 41. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 42. Ancestry.com Corporate Summary
Table 43. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 44. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 45. Quest Diagnostics Corporate Summary
Table 46. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 47. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 48. Gene By Gene Corporate Summary
Table 49. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 50. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 51. DNA Diagnostics Center Corporate Summary
Table 52. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 53. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 54. Invitae Corporate Summary
Table 55. Invitae Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 56. Invitae Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 57. IntelliGenetics Corporate Summary
Table 58. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 59. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 60. Ambry Genetics Corporate Summary
Table 61. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 62. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 63. Living DNA Corporate Summary
Table 64. Living DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 65. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 66. EasyDNA Corporate Summary
Table 67. EasyDNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 68. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 69. Pathway Genomics Corporate Summary
Table 70. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 71. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 72. Centrillion Technology Corporate Summary
Table 73. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 74. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 75. Xcode Corporate Summary
Table 76. Xcode Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 77. Xcode Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 78. Color Genomics Corporate Summary
Table 79. Color Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 80. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 81. Anglia DNA Services Corporate Summary
Table 82. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 83. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 84. African Ancestry Corporate Summary
Table 85. African Ancestry Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 86. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 87. Canadian DNA Services Corporate Summary
Table 88. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 89. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 90. DNA Family Check Corporate Summary
Table 91. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 92. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 93. Alpha Biolaboratories Corporate Summary
Table 94. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 95. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 96. Test Me DNA Corporate Summary
Table 97. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 98. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 99. 23 Mofang Corporate Summary
Table 100. 23 Mofang Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 101. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 102. Genetic Health Corporate Summary
Table 103. Genetic Health Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 104. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 105. DNA Services of America Corporate Summary
Table 106. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 107. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 108. Shuwen Health Sciences Corporate Summary
Table 109. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 110. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 111. Mapmygenome Corporate Summary
Table 112. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 113. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 114. Full Genomes Corporate Summary
Table 115. Full Genomes Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 116. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Direct-to-consumer Disease Risk and Health Test Segment by Type in 2021
Figure 2. Direct-to-consumer Disease Risk and Health Test Segment by Application in 2021
Figure 3. Global Direct-to-consumer Disease Risk and Health Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
Figure 8. By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 12. US Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 16. Germany Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 24. China Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 30. Brazil Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 33. Turkey Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 37. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Invitae Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Xcode Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Direct-to-consumer Disease Risk and Health Test Segment by Type in 2021
Figure 2. Direct-to-consumer Disease Risk and Health Test Segment by Application in 2021
Figure 3. Global Direct-to-consumer Disease Risk and Health Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
Figure 8. By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 12. US Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 16. Germany Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 24. China Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 30. Brazil Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 33. Turkey Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 37. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Invitae Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Xcode Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
